ֱ

Meeting Coverage

ASCO Expert Video Roundtable: Multiple Myeloma

Expert Video Roundtable from the American Society of Clinical Oncology

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

Joseph Mikhael, MD, leads a discussion on the DREAMM-7 and DREAMM-8 trials

image

Latest ASCO Expert Video Roundtable: Multiple Myeloma Meeting Coverage

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma

Joseph Mikhael, MD, leads a discussion on the subgroup analysis of CARTITUDE-4

June 27, 2024
Using MRD Status to Deescalate Multiple Myeloma Therapy

Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study

June 20, 2024
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma

Joseph Mikhael, MD, leads a roundtable discussion on two positive phase III trials from ASCO

June 14, 2024
Bispecifics-Based Combination Therapy in Multiple Myeloma

Sarah Holstein leads a roundtable discussion on the combination of bispecifics in MM

July 10, 2023
New Data on BCMA-Directed Bispecifics in Multiple Myeloma

Sarah Holstein leads a roundtable discussion on updates in the class

July 3, 2023
CAR-T Bests Standard Options in Lenalidomide-Refractory Multiple Myeloma

Sarah Holstein, MD, leads a roundtable discussion on the CARTITUDE-4 results

June 26, 2023
A Look at the Multiple Myeloma Data Leading to Blenrep's Withdrawal

Sarah Holstein leads a roundtable discussion on the DREAMM-3 results

June 20, 2023

Latest Oncology/Hematology Meeting Coverage